| 1. |
|
|
| 2. |
- Byrne, P., et al.
(författare)
-
A simulation of the tertiary current density distribution from a chlorate cell - I. Mathematical model
- 2001
-
Ingår i: Journal of the Electrochemical Society. - : The Electrochemical Society. - 0013-4651 .- 1945-7111. ; 148:10, s. D125-D132
-
Tidskriftsartikel (refereegranskat)abstract
- Numerical modeling is becoming an integral part of all research and development within the field of electrolytic systems. A numerical model that calculates the current density distribution and concentration profiles of a chlorate cell is presented here, The results are shown as functions of electrolyte velocity and exchange current density. The model takes into account the three transport mechanisms; diffusion, migration, and convection by considering the development of the flow velocity vector through the channel. It was seen that the developing velocity profile influences the concentration overpotentials, which in turn influences current density distributions. Results from the model show that the total current density decreased along the length of the anode, and that this distribution varied more at lower velocities. In addition, it was seen that migration contributes significantly to species transport, even within the diffusion layer. Finally, the model indicates that the hypochlorite ion is the main participant in the principal side reaction producing oxygen, and not the hypochlorous acid molecule. The results are useful as they increase knowledge of the chlorate process, and can be used to simulate future systems with a wide range of varying parameters such as cell geometry, flow, electrolyte composition, and electrode materials. The aim of the model is to use it as a tool for identifying the sources that contribute to the overpotential in the cell. This article concentrates on the concentration overpotential, which is one of the phenomena that can actually be influenced,
|
|
| 3. |
- Dacke, Marie, et al.
(författare)
-
Insect orientation to polarized moonlight
- 2003
-
Ingår i: Nature. - : Springer Science and Business Media LLC. - 0028-0836 .- 1476-4687. ; 424:6944, s. 33-33
-
Tidskriftsartikel (refereegranskat)
|
|
| 4. |
|
|
| 5. |
- Kelly, BD, et al.
(författare)
-
Obstetric adversity and age at first presentation with schizophrenia: Evidence of a dose-response relationship
- 2004
-
Ingår i: American Journal of Psychiatry. - 1535-7228. ; 161:5, s. 920-922
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: The purpose of the study was to determine if a dose-response relationship exists between obstetric adversity and age at first presentation with schizophrenia. Method: The Dublin Psychiatric Case Register was used to identify subjects with schizophrenia. Data on obstetric complications, social class of origin, and family history of psychiatric illness were obtained for those subjects. Results: A total of 409 patients with ICD-9 schizophrenia were identified. Patients with a history of obstetric complications presented earlier to psychiatric services. As the number of complications increased, the mean age at first presentation decreased. This effect was independent of social class of origin and family history of psychiatric illness. Conclusions: Obstetric adversity exerts an independent influence on the age at first presentation with schizophrenia, in a dose-response manner. This finding supports the existence of a causal relationship between obstetric adversity and age at first presentation with schizophrenia.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Ädelroth, E, et al.
(författare)
-
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis
- 2000
-
Ingår i: Journal of Allergy and Clinical Immunology. - : Elsevier BV. - 0091-6749 .- 1097-6825. ; 106:2, s. 253-259
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Allergic rhinitis is a common condition often requiring treatment. Objective: We evaluated whether recombinant humanized (rhu)mAb-E25, a recombinant humanized construct of a murine antibody that binds to circulating IgE, could control symptoms and reduce intake of concomitant medication in seasonal allergic rhinitis (SAR) induced by birch pollen if given subcutaneously in a dose schedule predicted to reduce serum free IgE levels below 25 ng/mL. Methods: We randomly assigned 251 adult subjects with a history of SAR and a positive skin test response to birch pollen to receive 300 mg of rhumAb-E25 or placebo given 2 or 3 times during the season, depending on baseline IgE levels. The primary efficacy variable was the subject's average daily nasal symptom severity score (sneezing, itching, runny, and stuffy nose) from diary data collected over the double-blind treatment period. Secondary efficacy variables included the average number of rescue antihistamine tablets per day, the proportion of days with any SAR medication use, and rhinoconjunctivitis-specific quality of life (QOL). Results: Significant between-treatment differences in favor of rhumAb-E25 were observed in average daily nasal symptom severity scores, the average number of tablets of rescue antihistamines per day, the proportion of days with any SAR medication use, and all domains of QOL. Serum-free IgE levels were markedly lower in rhumAb-E25-treated subjects and were associated with clinical effectiveness. Recombinant humanized mAb-E25 was well tolerated. No anti-rhumAb-E25 antibodies were detected. Conclusion: Compared with placebo, rhumAb-E25 was safe and effective in controlling birch pollen-induced SAR symptoms, with less concomitant medication use and improved QOL. This study shows the therapeutic potential of anti-IgE antibody in SAR.
|
|
